Prospera Financial Services Inc Organon & Co. Transaction History

Prospera Financial Services Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$31.66 - $38.9 $10,922 - $13,420	-345 Reduced 25.56%	1,005 $34,000
Q1 2022 May 04, 2022	SELL	$30.45 - $39.36 $202,127 - $261,271	-6,638 Reduced 83.1%	1,350 $47,000
Q4 2021 Feb 10, 2022	BUY	$28.67 - $37.13 $22,477 - $29,109	784 Added 10.88%	7,988 $244,000
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $1.45 Million - $1.81 Million	-50,683 Reduced 87.56%	7,204 $236,000
Q2 2021 Aug 12, 2021	BUY	$28.45 - $38.0 $1.65 Million - $2.2 Million	57,887 New	57,887 $78,000

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

Stay updated on Prospera Financial Services Inc with notifications on news.